PAPER Altomare D, Caprioglio C, Assal F, Allali G, Mendes A, Ribaldi F, Ceyzeriat K, Martins M, Tomczyk S, Stampacchia S, Dodich A, Boccardi M, Chicherio C, Frisoni GB, Garibotto V

Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison.

Eur J Nucl Med Mol Imaging. 2021 Feb 27; PubMed: 33638661

PAPER Watt JA, Veroniki AA, Tricco AC, Straus SE

Using a distribution-based approach and systematic review methods to derive minimum clinically important differences.

BMC Med Res Methodol. 2021 Feb 26;21(1):41. PubMed: 33637039

PAPER Haddad M, Hervé V, Ben Khedher MR, Rabanel JM, Ramassamy C

Glutathione: an old and small molecule with great functions and new applications in the brain and in Alzheimer's disease.

Antioxid Redox Signal. 2021 Feb 26; PubMed: 33637005

PAPER Ruppert MC, Greuel A, Freigang J, Tahmasian M, Maier F, Hammes J, van Eimeren T, Timmermann L, Tittgemeyer M, Drzezga A, Eggers C

The default mode network and cognition in Parkinson's disease: A multimodal resting-state network approach.

Hum Brain Mapp. 2021 Feb 27; PubMed: 33638213

PAPER Baik K, Kim SM, Jung JH, Lee YH, Chung SJ, Yoo HS, Ye BS, Lee PH, Sohn YH, Kang SW, Kang SY

Donepezil for mild cognitive impairment in Parkinson's disease.

Sci Rep. 2021 Feb 26;11(1):4734. PubMed: 33637811

PAPER Baxter PS, Márkus NM, Dando O, He X, Al-Mubarak BR, Qiu J, Hardingham GE

Targeted de-repression of neuronal Nrf2 inhibits α-synuclein accumulation.

Cell Death Dis. 2021 Feb 26;12(2):218. PubMed: 33637689

PAPER Jansson D, Dieriks VB, Rustenhoven J, Smyth LC, Scotter E, Aalderink M, Feng S, Johnson R, Schweder P, Mee E, Heppner P, Turner C, Curtis M, Faull R, Dragunow M

Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus.

Commun Biol. 2021 Feb 26;4(1):260. PubMed: 33637884

PAPER Dai X, Fu W, Chi H, Mesias VS, Zhu H, Leung CW, Liu W, Huang J

Optical tweezers-controlled hotspot for sensitive and reproducible surface-enhanced Raman spectroscopy characterization of native protein structures.

Nat Commun. 2021 Feb 26;12(1):1292. PubMed: 33637710

PAPER Agnello L, Colletti T, Lo Sasso B, Vidali M, Spataro R, Gambino CM, Giglio RV, Piccoli T, Bivona G, La Bella V, Ciaccio M

Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis.

Eur J Neurol. 2021 Feb 26; PubMed: 33638255

PAPER Winek K, Soreq H, Meisel A

Regulators of cholinergic signaling in disorders of the central nervous system.

J Neurochem. 2021 Feb 26; PubMed: 33638173

PAPER Khodarahmi R, Akbari V, Mohammadi S, Farshadnia T, Rahimabadi MM, Goicoechea HC, Jalalvand AR

Chemometric modeling of the electrochemical data to investigate proline cis/trans isomeration effect on aggregation of Tau protein.

Protein Expr Purif. 2021 Jun;182:105858. Epub 2021 Feb 25 PubMed: 33639278

PAPER Sieben A, Van Langenhove T, Vermeiren Y, Gossye H, Praet M, Vanhauwaert D, Cousaert C, Engelborghs S, Raedt R, Boon P, Santens P, De Deyn PP, Bracke KR, De Meulemeester K, Van Broeckhoven C, Martin JJ, Bjerke M

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.

J Neuropathol Exp Neurol. 2021 Mar 22;80(4):313-324. PubMed: 33638350

PAPER Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, Fonte P

Intranasal drug delivery for treatment of Alzheimer's disease.

Drug Deliv Transl Res. 2021 Apr;11(2):411-425. Epub 2021 Feb 26 PubMed: 33638130

PAPER Castagna A, Manzo C, Fabbo A, Lacava R, Ruberto C, Ruotolo G

Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease.

Clin Drug Investig. 2021 Apr;41(4):413. PubMed: 33638864

PAPER van de Beek M, van Steenoven I, van der Zande JJ, Porcelijn I, Barkhof F, Stam CJ, Raijmakers PG, Scheltens P, Teunissen CE, van der Flier WM, Lemstra AW

Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results.

Alzheimers Res Ther. 2021 Feb 26;13(1):53. PubMed: 33637117